HC Wainwright Reiterates Buy Rating for Marinus Pharmaceuticals (NASDAQ:MRNS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Oppenheimer Reiterates Market Perform Rating for Marinus Pharmaceuticals (NASDAQ:MRNS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com downgraded shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Wednesday. Several other brokerages also recently weighed in on MRNS. Truist Financial cut their price target on Marinus Pharmaceuticals from $32.00 to $25.00 and set a buy rating on […]
Royal Bank of Canada reissued their outperform rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $24.00 target price on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on the stock. Truist Financial cut […]
StockNews.com lowered shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning. MRNS has been the subject of several other reports. Truist Financial reduced their target price on shares of Marinus Pharmaceuticals from $32.00 to $25.00 and set a buy rating […]